Xiao Yuangui – Trademark Portfolio

Entity Type: 01

Xiao Yuangui holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ASDAYCM and TWISERN. The owner is based in ZHAOQING, GUANGDONG.

NO.17, BLK 4, BUSINESS ZONE MANAGEMENT

COMMITTEE,, HIGH-TECH DEVELOPMENT ZONE

ZHAOQING, GUANGDONG 000000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ASDAYCM
ASDAYCM
Registered 2021
TWISERN
TWISERN
Registered 2020

Trademark Classifications

Xiao Yuangui's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does Xiao Yuangui have?

Xiao Yuangui has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Xiao Yuangui file in?

Xiao Yuangui files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 7 (Machinery). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Xiao Yuangui's most well-known trademarks?

Xiao Yuangui's registered trademark portfolio includes well-known marks such as ASDAYCM and TWISERN. These are among 2 currently registered trademarks in the portfolio.

What is Xiao Yuangui's trademark registration success rate?

Xiao Yuangui has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.